You're listing the outstanding shares and comparing to authorized shares. Apples and oranges. MNKD had 550 million authorized shares, but 367 million outstanding, for example. There are a lot of possible reasons for this increase. GC reiterated yesterday that there are no plans to raise funds for current operations. He also said he'd provide an explanation in a blog on Monday. I go back to the addition of Huffman who has expertise in mergers, acquisitions, and spin-offs. The introductory information in that PR didn't have to list those things, but GC made a point to include that. There are just as many, if not more, positives possible from this increase (merger, acquisition, spinoff) than negatives (dilutive financing) and that negative has been nixed by GC already in his tweet response to Slurppie yesterday. All of this emotional speculation is what led to the last crash. Either you trust the company or you don't. I guess we'll know more on Monday.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links